Nearly 70% of cancer drugs granted FDA accelerated approval between 2011 and 2020 required safety updates within 4 years. For patients with noncardioembolic ischemic stroke or high-risk transient ...

Hematology refers to the study of blood and bone marrow conditions. A person may be referred to a hematologist to find out what the cause of anemia is and to determine a treatment plan. Anemia occurs ...

FDA accepts New Drug Application for iberdomide in relapsed or refractory multiple myeloma. Iberdomide is being evaluated in combination with standard treatment for patients who have already received ...

A distinguished expert in health care, Alexis Johnson, MSN, currently works at the University of Alabama at Birmingham, ...

The UAB Pediatric Hematology-Oncology Fellowship Program is a three-year training program approved by the Accreditation Council for Graduate Medical Education and affiliated with the Pediatric ...

The Saint Louis University Division of Hematology and Medical Oncology offers a three-year subspecialty fellowship that emphasizes on inpatient and outpatient care, as well as developing the teaching ...

The SSM Health/Saint Louis University Division of Hematology and Medical Oncology offers a three-year subspecialty residency that places an emphasis on inpatient and outpatient care, as well as ...

The Alabama Center for Childhood Cancer and Blood Disorders is much more than a place. It is an extraordinary partnership of local, national and international centers of excellence that provides care ...

The mission of our ACGME-accredited fellowship is to provide an environment to develop the next generation of leaders in the fields of hematology and oncology. By utilizing resources and mentors ...